References
- Hinz A, Krauss O, Hauss JP, et al. Anxiety and depression in cancer patients compared with the general population. Eur J Cancer Care. 2010;19(4):522–529.
- Vodermaier A, Linden W, MacKenzie R, Greig D, Marshall C. Disease stage predicts post-diagnosis anxiety and depression only in some types of cancer. Br J Cancer. 2011;105(12):1814.
- Lagergren J, Mattson F. Diverging trends in recent population-based survival rates in oesophageal and gastric cancer. PloS One. 2012;7(7):e41352.
- Rutegård M, Charonis K, Lu Y, Lagergren P, Lagergren J, Rouvelas I. Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery. 2012;152(5):903–910.
- Sjoquist KM, Burmeister BH, Smithers BM, et al., and the Australasian Gastro-Intestinal Trials Group. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12(7):681–692.
- Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, Lagergren J. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol. 2005;6(11):864–870.
- Dewberry LC, Wingrove LJ, Marsh MD, et al. Pilot prehabilitation program for patients with esophageal cancer during neoadjuvant therapy and surgery. J Surg Res. 2019;235:66–72.
- Holland JC. Update: NCCN practice guidelines for the management of psychosocial distress. Oncology-Huntington. 1999;13(11):459–507.
- Pirl WF, Fann JR, Greer JA, et al. Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer. 2014;120(19):2946–2954.